Phillip Gutry

Phillip Gutry

Inga fler pågående positioner
52 år
Health Technology
Finance
Consumer Services

Profil

Phillip P.
Gutry
worked as a Director of Corporate Development at Gilead Sciences, Inc. from 2006 to 2011.
He then worked as a Principal at MPM BioImpact, Inc. from 2011 to 2015.
From 2015 to 2018, he was an Executive Director of Business Development at Regeneron Pharmaceuticals, Inc. He also served as a Director at Potenza Therapeutics, Inc. and Amphivena Therapeutics, Inc. Additionally, he was an Independent Director at Avalo Therapeutics, Inc. from 2015 to 2021.
From 2018 to 2020, he was the Chief Business Officer at Kronos Bio, Inc. and later served as the CFO, Chief Business & Accounting Officer at Graphite Bio, Inc. Mr. Gutry received his undergraduate degree from Dartmouth College and his MBA from The Wharton School of the University of Pennsylvania.

Tidigare kända positioner av Phillip Gutry

FöretagPositionSlut
AVALO THERAPEUTICS, INC. Direktör/Styrelseledamot 2021-11-01
KRONOS BIO, INC. Företagsledare/Principal 2020-10-01
REGENERON PHARMACEUTICALS, INC. Företagsledare/Principal 2018-10-01
Privat kapitalinvesterare 2015-06-01
GILEAD SCIENCES, INC. Företagsledare/Principal 2011-05-01
Se detaljerna i Phillip Gutrys erfarenhet

Phillip Gutrys utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

64

Första gradens relationer

12

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag12

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Services

Finance

Health Technology

Retail Trade

Consumer Services

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Phillip Gutry
SENASTE TIDEN | -40%: De bästa verktygen för prenumeranter för att identifiera morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU